Advertisement

neurogenetics

, Volume 18, Issue 4, pp 195–205 | Cite as

Molecular diversity of combined and complex dystonia: insights from diagnostic exome sequencing

  • Michael Zech
  • Robert Jech
  • Matias Wagner
  • Tobias Mantel
  • Sylvia Boesch
  • Michael Nocker
  • Angela Jochim
  • Riccardo Berutti
  • Petra Havránková
  • Anna Fečíková
  • David Kemlink
  • Jan Roth
  • Tim M. Strom
  • Werner Poewe
  • Evžen Růžička
  • Bernhard Haslinger
  • Juliane WinkelmannEmail author
Original Article

Abstract

Combined and complex dystonias are heterogeneous movement disorders combining dystonia with other motor and/or systemic signs. Although we are beginning to understand the diverse molecular causes of these disease entities, clinical pattern recognition and conventional genetic workup achieve an etiological diagnosis only in a minority of cases. Our goal was to provide a window into the variable genetic origins and distinct clinical patterns of combined/complex dystonia more broadly. Between August 2016 and January 2017, we applied whole-exome sequencing to a cohort of nine patients with varied combined and/or complex dystonic presentations, being on a diagnostic odyssey. Bioinformatics analyses, co-segregation studies, and sequence-interpretation algorithms were employed to detect causative mutations. Comprehensive clinical review was undertaken to define the phenotypic spectra and optimal management strategies. On average, we observed a delay in diagnosis of 23 years before whole-exome analysis enabled determination of each patient’s genetic defect. Whereas mutations in ACTB, ATP1A3, ADCY5, and SGCE were associated with particular phenotypic clues, trait manifestations arising from mutations in PINK1, MRE11A, KMT2B, ATM, and SLC6A1 were different from those previously reported in association with these genes. Apart from improving counseling for our entire cohort, genetic findings had actionable consequences on preventative measures and therapeutic interventions for five patients. Our investigation confirms unique genetic diagnoses, highlights key clinical features and phenotypic expansions, and suggests whole-exome sequencing as a first-tier diagnostic for combined/complex dystonia. These results might stimulate independent teams to extend the scope of agnostic genetic screening to this particular phenotypic group that remains poorly characterized through existing studies.

Keywords

Combined dystonia Complex dystonia Exome Mutation Genetic heterogeneity 

Notes

Acknowledgements

We thank all patients with dystonia and their family members who participated in this study.

Funding

This study was funded by in-house institutional funding from Technische Universität München, Munich, Germany, Helmholtz Zentrum München, Munich, Germany, and Medizinische Universität Innsbruck, Innsbruck, Austria, as well as the Czech Science Foundation (grant: GACR16-13323S), and Charles University, Prague, Czech Republic (project: Progres Q27/LF1).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study. Additional informed consent was obtained from all individual participants for whom identifying information is included in this article.

Disclosures concerning the present manuscript

Nothing to report.

Supplementary material

ESM 1

Case 3 (PINK1 mutation) A 56-year-old woman presenting dystonia-parkinsonism syndrome. This video was taken after GPi-DBS at the age 51 years. Dystonic symptoms responded favorably to this intervention, whereas dysarthria and right-sided bradykinesia persisted. Case 5 (MRE11A mutation) A 27-year-old woman presenting generalized dystonia with predominant tremulous cervical dystonia, abnormal upper-limb posturing, and intermittent dystonic trunk movements. Dystonic symptoms were accompanied by myoclonic-like jerky movements. Case 7 (KMT2B mutation) A 13-year-old girl presenting generalized dystonia involving the neck, trunk, and extremities. Dystonia was combined with non-motor features including strabismus, mild facial dysmorphia (bulbous nasal tip), intellectual disability, and hearing impairment. Case 8 (ATM mutation) A 51-year-old woman with segmental cranio-cervical dystonia, consisting of tremulous torticollis and oromandibular dystonia. The latter symptom produced speech impairment. (MOV 27990 kb)

10048_2017_521_MOESM2_ESM.pdf (102 kb)
ESM 2 (PDF 102 kb)

References

  1. 1.
    Sanger TD, Chen D, Fehlings DL et al (2010) Definition and classification of hyperkinetic movements in childhood. Mov Disord 25:1538–1549CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Albanese A, Bhatia K, Bressman SB et al (2013) Phenomenology and classification of dystonia: a consensus update. Mov Disord 28:863–873CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Marras C, Lang A, van de Warrenburg BP et al (2016) Nomenclature of genetic movement disorders: recommendations of the international Parkinson and movement disorder society task force. Mov Disord 31:436–457CrossRefPubMedGoogle Scholar
  4. 4.
    van Egmond ME, Kuiper A, Eggink H et al (2015) Dystonia in children and adolescents: a systematic review and a new diagnostic algorithm. J Neurol Neurosurg Psychiatry 86:774–781CrossRefPubMedGoogle Scholar
  5. 5.
    Fung VS, Jinnah HA, Bhatia K, Vidailhet M (2013) Assessment of patients with isolated or combined dystonia: an update on dystonia syndromes. Mov Disord 28:889–898CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Lin JP, Lumsden DE, Gimeno H, Kaminska M (2014) The impact and prognosis for dystonia in childhood including dystonic cerebral palsy: a clinical and demographic tertiary cohort study. J Neurol Neurosurg Psychiatry 85:1239–1244CrossRefPubMedGoogle Scholar
  7. 7.
    Zech M, Boesch S, Jochim A et al (2017) Clinical exome sequencing in early-onset generalized dystonia and large-scale resequencing follow-up. Mov Disord 32:549–559CrossRefPubMedGoogle Scholar
  8. 8.
    van Egmond ME, Lugtenberg CH (2017) Brouwer OF, et al. A post hoc study on gene panel analysis for the diagnosis of dystonia, Mov DisordGoogle Scholar
  9. 9.
    Lohmann K, Klein C (2017) Update on the genetics of dystonia. Curr Neurol Neurosci Rep 17:26CrossRefPubMedGoogle Scholar
  10. 10.
    Trujillano D, Bertoli-Avella AM, Kumar Kandaswamy K et al (2017) Clinical exome sequencing: results from 2819 samples reflecting 1000 families. Eur J Hum Genet 25:176–182CrossRefPubMedGoogle Scholar
  11. 11.
    Jinnah HA, Alterman R, Klein C et al (2017) Deep brain stimulation for dystonia: a novel perspective on the value of genetic testing. J Neural Transm (Vienna) 124:417–430CrossRefGoogle Scholar
  12. 12.
    Lill CM, Mashychev A, Hartmann C et al (2016) Launching the movement disorders society genetic mutation database (MDSGene). Mov Disord 31:607–609CrossRefPubMedGoogle Scholar
  13. 13.
    Zech M, Boesch S, Maier EM et al (2016) Haploinsufficiency of KMT2B, encoding the lysine-specific histone methyltransferase 2B, results in early-onset generalized dystonia. Am J Hum Genet 99:1377–1387CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Defazio G, Conte A, Gigante AF, Fabbrini G, Berardelli A (2015) Is tremor in dystonia a phenotypic feature of dystonia? Neurology 84:1053–1059CrossRefPubMedGoogle Scholar
  15. 15.
    Adzhubei IA, Schmidt S, Peshkin L et al (2010) A method and server for predicting damaging missense mutations. Nat Methods 7:248–249CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Kircher M, Witten DM, Jain P, O'Roak BJ, Cooper GM, Shendure J (2014) A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 46:310–315CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Landrum MJ, Lee JM, Riley GR et al (2014) ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res 42:D980–D985CrossRefPubMedGoogle Scholar
  18. 18.
    Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–424CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Amendola LM, Dorschner MO, Robertson PD et al (2015) Actionable exomic incidental findings in 6503 participants: challenges of variant classification. Genome Res 25:305–315CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Procaccio V, Salazar G, Ono S et al (2006) A mutation of beta-actin that alters depolymerization dynamics is associated with autosomal dominant developmental malformations, deafness, and dystonia. Am J Hum Genet 78:947–960CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Eggink H, van Egmond ME, Verschuuren-Bemelmans CC et al (2017) Dystonia-deafness syndrome caused by a beta-actin gene mutation and response to deep brain stimulation. Mov Disord 32:162–165CrossRefPubMedGoogle Scholar
  22. 22.
    Zanotti-Fregonara P, Vidailhet M, Kas A et al (2008) [123I]-FP-CIT and [99mTc]-HMPAO single photon emission computed tomography in a new sporadic case of rapid-onset dystonia-parkinsonism. J Neurol Sci 273:148–151CrossRefPubMedGoogle Scholar
  23. 23.
    Anselm IA, Sweadner KJ, Gollamudi S, Ozelius LJ, Darras BT (2009) Rapid-onset dystonia-parkinsonism in a child with a novel atp1a3 gene mutation. Neurology 73:400–401CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Tan EK, Refai FS, Siddique M et al (2009) Clinically reported heterozygous mutations in the PINK1 kinase domain exert a gene dosage effect. Hum Mutat 30:1551–1557CrossRefPubMedGoogle Scholar
  25. 25.
    Chen DH, Meneret A, Friedman JR et al (2015) ADCY5-related dyskinesia: broader spectrum and genotype-phenotype correlations. Neurology 85:2026–2035CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Sim CH, Gabriel K, Mills RD, Culvenor JG, Cheng HC (2012) Analysis of the regulatory and catalytic domains of PTEN-induced kinase-1 (PINK1). Hum Mutat 33:1408–1422CrossRefPubMedGoogle Scholar
  27. 27.
    Zimprich A, Grabowski M, Asmus F et al (2001) Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet 29:66–69CrossRefPubMedGoogle Scholar
  28. 28.
    Meyer E, Carss KJ, Rankin J et al (2017) Mutations in the histone methyltransferase gene KMT2B cause complex early-onset dystonia. Nat Genet 49:223–237CrossRefPubMedGoogle Scholar
  29. 29.
    Savitsky K, Bar-Shira A, Gilad S et al (1995) A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268:1749–1753CrossRefPubMedGoogle Scholar
  30. 30.
    Carvill GL, McMahon JM, Schneider A et al (2015) Mutations in the GABA transporter SLC6A1 cause epilepsy with myoclonic-atonic seizures. Am J Hum Genet 96:808–815CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Verloes A, Di Donato N, Masliah-Planchon J et al (2015) Baraitser-Winter cerebrofrontofacial syndrome: delineation of the spectrum in 42 cases. Eur J Hum Genet 23:292–301CrossRefPubMedGoogle Scholar
  32. 32.
    Miyamoto R, Morino H, Yoshizawa A et al (2014) Exome sequencing reveals a novel MRE11 mutation in a patient with progressive myoclonic ataxia. J Neurol Sci 337:219–223CrossRefPubMedGoogle Scholar
  33. 33.
    Havrankova P, Jech R, Roth J, Urgosik D, Ruzicka E (2009) Beneficial effect of deep brain stimulation of GPi in a patient with dystonia-deafness phenotype. Mov Disord 24:465–466CrossRefPubMedGoogle Scholar
  34. 34.
    Valente EM, Abou-Sleiman PM, Caputo V et al (2004) Hereditary early-onset Parkinson’s disease caused by mutations in PINK1. Science 304:1158–1160CrossRefPubMedGoogle Scholar
  35. 35.
    Stewart GS, Maser RS, Stankovic T et al (1999) The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell 99:577–587CrossRefPubMedGoogle Scholar
  36. 36.
    Directors ABo (2012) Points to consider in the clinical application of genomic sequencing. Genet Med 14:759–761CrossRefGoogle Scholar
  37. 37.
    Need AC, Shashi V, Schoch K, Petrovski S, Goldstein DB (2017) The importance of dynamic re-analysis in diagnostic whole exome sequencing. J Med Genet 54:155–156CrossRefPubMedGoogle Scholar
  38. 38.
    Sun Y, Ruivenkamp CA, Hoffer MJ et al (2015) Next-generation diagnostics: gene panel, exome, or whole genome? Hum Mutat 36:648–655CrossRefPubMedGoogle Scholar
  39. 39.
    Klein C, Djarmati A, Hedrich K et al (2005) PINK1, Parkin, and DJ-1 mutations in Italian patients with early-onset parkinsonism. Eur J Hum Genet 13:1086–1093CrossRefPubMedGoogle Scholar
  40. 40.
    Delia D, Piane M, Buscemi G et al (2004) MRE11 mutations and impaired ATM-dependent responses in an Italian family with ataxia-telangiectasia-like disorder. Hum Mol Genet 13:2155–2163CrossRefPubMedGoogle Scholar
  41. 41.
    Fernet M, Gribaa M, Salih MA, Seidahmed MZ, Hall J, Koenig M (2005) Identification and functional consequences of a novel MRE11 mutation affecting 10 Saudi Arabian patients with the ataxia telangiectasia-like disorder. Hum Mol Genet 14:307–318CrossRefPubMedGoogle Scholar
  42. 42.
    Carrillo F, Schneider SA, Taylor AM, Srinivasan V, Kapoor R, Bhatia KP (2009) Prominent oromandibular dystonia and pharyngeal telangiectasia in atypical ataxia telangiectasia. Cerebellum 8:22–27CrossRefPubMedGoogle Scholar
  43. 43.
    Saunders-Pullman R, Raymond D, Stoessl AJ et al (2012) Variant ataxia-telangiectasia presenting as primary-appearing dystonia in Canadian Mennonites. Neurology 78:649–657CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Charlesworth G, Mohire MD, Schneider SA, Stamelou M, Wood NW, Bhatia KP (2013) Ataxia telangiectasia presenting as dopa-responsive cervical dystonia. Neurology 81:1148–1151CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Palmer S, Towne MC, Pearl PL et al (2016) SLC6A1 mutation and ketogenic diet in epilepsy with myoclonic-atonic seizures. Pediatr Neurol 64:77–79CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Lumsden DE (2017) How might a genetic diagnosis benefit children with dystonia? Eur J Paediatr Neurol 21:245–246CrossRefPubMedGoogle Scholar
  47. 47.
    Lohmann E, Gasser T, Grundmann K (2017) Needs and requirements of modern biobanks on the example of dystonia syndromes. Front Neurol 8:9CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany 2017

Authors and Affiliations

  • Michael Zech
    • 1
    • 2
  • Robert Jech
    • 3
  • Matias Wagner
    • 1
    • 4
  • Tobias Mantel
    • 2
  • Sylvia Boesch
    • 5
  • Michael Nocker
    • 5
  • Angela Jochim
    • 2
  • Riccardo Berutti
    • 6
  • Petra Havránková
    • 3
  • Anna Fečíková
    • 3
  • David Kemlink
    • 3
  • Jan Roth
    • 3
  • Tim M. Strom
    • 4
    • 6
  • Werner Poewe
    • 5
  • Evžen Růžička
    • 3
  • Bernhard Haslinger
    • 2
  • Juliane Winkelmann
    • 1
    • 2
    • 4
    • 7
    Email author
  1. 1.Institut für NeurogenomikHelmholtz Zentrum MünchenNeuherbergGermany
  2. 2.Klinik und Poliklinik für Neurologie, Klinikum rechts der IsarTechnische Universität MünchenMunichGermany
  3. 3.Department of Neurology and Center of Clinical Neuroscience, First Faculty of MedicineCharles University and General Faculty HospitalPragueCzech Republic
  4. 4.Institut für HumangenetikTechnische Universität MünchenMunichGermany
  5. 5.Department of NeurologyMedical University InnsbruckInnsbruckAustria
  6. 6.Institut für HumangenetikHelmholtz Zentrum MünchenMunichGermany
  7. 7.Munich Cluster for Systems Neurology, SyNergyMunichGermany

Personalised recommendations